Market closedNon-fractional

scPharmaceuticals/SCPH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About scPharmaceuticals

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Ticker

SCPH

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Burlington, United States

Employees

136

SCPH Metrics

BasicAdvanced
$159M
Market cap
-
P/E ratio
-$1.49
EPS
0.09
Beta
-
Dividend rate
$159M
0.09
6.212
5.257
165.342
166.091
-7.22%
-36.26%
-114.99%
9.705
6.48
6.48
-2.829
754.68%
14.23%
6.74%

What the Analysts think about SCPH

Analyst Ratings

Majority rating from 6 analysts.
Buy

SCPH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-231.14% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$6.1M
1.67%
Net income
-$14M
2.17%
Profit margin
-231.14%
0.50%

SCPH Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 17.62%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.36
-$0.41
-$0.35
-$0.36
-
Expected
-$0.37
-$0.36
-$0.42
-$0.44
-$0.40
Surprise
-3.33%
12.38%
-16.43%
-17.62%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for scPharmaceuticals stock?

scPharmaceuticals (SCPH) has a market cap of $159M as of July 06, 2024.

What is the P/E ratio for scPharmaceuticals stock?

The price to earnings (P/E) ratio for scPharmaceuticals (SCPH) stock is 0 as of July 06, 2024.

Does scPharmaceuticals stock pay dividends?

No, scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next scPharmaceuticals dividend payment date?

scPharmaceuticals (SCPH) stock does not pay dividends to its shareholders.

What is the beta indicator for scPharmaceuticals?

scPharmaceuticals (SCPH) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell scPharmaceuticals stock

Buy or sell scPharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing